Need Help?
Copied to clipboard!

Comparative transcriptomics reveal molecular convergence and divergence in parkinsonian disorders

Elucidate the biological convergence and divergence across the parkinsonian spectrum. The study contains data processed at two different sites as well as Alzheimer's disease as an non-parkinsonian control. Specifically, Parkinson's disease (PD, N=448), dementia with Lewy bodies (DLB, N=80), multiple system atrophy (MSA, N=35), progressive supranuclear palsy (PSP, n=42), corticobasal degeneration (CBD, n=17), Alzheimer's disease (AD, N=72) and neurologically healthy controls (N=283). RNA-seq was carried out using ribosomal depletion.

Cite

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD50000002623 Illumina HiSeq 2500 42
EGAD50000002624 Illumina HiSeq 2500 35
EGAD50000002625 Illumina HiSeq 2500 72
EGAD50000002626 Illumina HiSeq 2500 80
EGAD50000002627 Illumina HiSeq 2500 448
EGAD50000002628 Illumina HiSeq 2500 283
EGAD50000002629 Illumina HiSeq 2500 17